Nancy Tray
About Nancy Tray
Nancy Tray is a Cellular Therapy Account Manager at Kite Pharma, with a background in oncology and anti-infectives. She has extensive experience in account management, relationship building, and reimbursement processes, having previously worked at Gilead Sciences and Janssen Pharmaceutica.
Current Role at Kite Pharma
Nancy Tray serves as a Cellular Therapy Account Manager at Kite Pharma, a position she has held since 2023. In this role, she operates within the Pittsburgh-Cleveland area, focusing on the promotion and management of cellular therapy products. Her responsibilities include engaging with healthcare professionals and decision-makers to facilitate the adoption of innovative therapies.
Previous Experience at Gilead Sciences
Prior to her current role, Nancy Tray worked as a Senior Therapeutic Specialist at Gilead Sciences from 2022 to 2023. During her time in Pittsburgh, Pennsylvania, she specialized in therapeutic areas relevant to oncology and anti-infectives, contributing to the company's efforts in these markets.
Professional Background in Pharmaceuticals
Nancy Tray has a diverse background in the pharmaceutical industry, having held positions at several companies. She worked as an Area Business Specialist at Janssen Pharmaceutica for six months in 2010 and as a Sales Representative at Ortho-McNeil Pharmaceutical from 2001 to 2004. Her experiences have equipped her with strong skills in account and territory management.
Education and Expertise in Sports Medicine
Nancy Tray studied at the University of Pittsburgh, where she earned a Bachelor of Science in Sports Medicine from 1993 to 1997 and a Master of Science in Sports Medicine from 1997 to 1999. Her educational background provides her with a solid foundation in medical knowledge, which complements her expertise in oncology and anti-infectives.
Skills in Account Management and Contract Negotiation
Nancy Tray possesses strong skills in account and territory management, particularly in the buy and bill process and reimbursement for injectables. She has a proven ability to build and maintain relationships with high-level decision-makers in hospital settings. Additionally, she demonstrates a deep understanding of contracting complexities and the evolving reimbursement landscape.